| Literature DB >> 31922113 |
Jyotsna Agarwal1, Shruti Radera2, Swastika Suvirya3, Manish Awasthi2.
Abstract
Entities:
Year: 2019 PMID: 31922113 PMCID: PMC6896391 DOI: 10.4103/ijstd.IJSTD_48_16
Source DB: PubMed Journal: Indian J Sex Transm Dis AIDS ISSN: 2589-0557
Antibiotic sensitivity profile in Neisseria gonorrhoeae
| Antibiotics | CLSI guidelines method ( | CDS method ( | ||||
|---|---|---|---|---|---|---|
| R | MS | S | R | LS | S | |
| Penicillina | 4 | 2 | 0 | 3 (PPNG) | 2 | 0 |
| Ciprofloxacinb | 5 | - | 1 | 5 | 0 | 0 |
| Spectinomycin | - | - | - | 0 | 0 | 5 |
| Tetracycline | 3 | 1 | 2 | 4 (TRNG) | 1 | 0 |
| Azithromycin | - | - | - | 0 | 0 | 5 |
| Cefixime | - | - | - | 0 | 0 | 5 |
| Ceftriaxonec | 1 | 0 | 5 | 0 | 0 | 5 |
By the Clinical and Laboratory Standards Institute guidelines and calibrated dichotomous susceptibility method. *One Neisseria gonorrhoeae isolate sent to apex laboratory could not be revived; aPenicillin disc potency: 10 IU (CLSI guidelines), 0.5 IU (CDS method); bCiprofloxacin disc potency: 5 μg (CLSI guidelines), 1 μg (CDS method); cCeftriaxone disc potency: 30 μg (CLSI guidelines), 0.5 μg (CDS method). PPNG=Penicillinase-producing Neisseria gonorrhoeae; TRNG=Tetracycline-resistant Neisseria gonorrhoeae; CLSI=Clinical and Laboratory Standards Institute; CDS=Calibrated dichotomous susceptibility; S=Susceptible; LS=Less susceptible; MS=Moderately susceptible; R=Resistant